NRIX Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Nurix Therapeutics Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 15.9 USD 6.35%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast NRIX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NRIX is 25.09 USD with a low forecast of 14.14 USD and a high forecast of 36.75 USD.

NRIX Lowest Forecast

Wall Street Target

NRIX Average Forecast

Wall Street Target

NRIX Highest Forecast

Wall Street Target

11% Downside

58% Upside

131% Upside

The latest public price target was made on Apr 11, 2024 by Gregory Renza from RBC Capital , who expects NRIX stock to rise by 45% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Gregory Renza RBC Capital	23 USD Upside 45%	1 month ago Apr 11, 2024	Nurix (NRIX) PT Raised to $23 at RBC Capital StreetInsider
Joel Beatty Robert W. Baird	25 USD Upside 57%	1 month ago Apr 11, 2024	Nurix (NRIX) PT Raised to $25 at Baird StreetInsider

Price Target	23 USD
Upside/Downside	45%

Price Target	25 USD
Upside/Downside	57%

Immuneering Corp

746% Upside

Precision BioSciences Inc

178% Upside

Zealand Pharma A/S

24% Upside

Solasia Pharma KK

210% Upside

Immuneering Corp

746% Upside

Precision BioSciences Inc

178% Upside

Zealand Pharma A/S

24% Upside

Solasia Pharma KK

210% Upside

Takara Bio Inc

73% Upside

Sinocelltech Group Ltd

49% Upside

Shenzhen Weiguang Biological Products Co Ltd

41% Upside

Blueprint Medicines Corp

13% Upside

Revenue
Forecast

For the last 4 years the compound annual growth rate for Nurix Therapeutics Inc's revenue is 25%. The projected CAGR for the next 3 years is 22%.

25%

22%

-13%

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

3%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-21%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for NRIX is 25.09 USD with a low forecast of 14.14 USD and a high forecast of 36.75 USD.

For the last 4 years the compound annual growth rate for Nurix Therapeutics Inc's revenue is 25%. The projected CAGR for the next 3 years is 22%.

Join more than 137,700+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.